Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Jazz Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference



DUBLIN, Dec. 7, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the BMO Capital Markets Healthcare Conference in New York, NY. 

Matt Young, executive vice president and chief financial officer, will provide an overview of the company and a business and financial update at the conference on Thursday, December 14, 2017 at 10:30 a.m. EST / 3:30 p.m. GMT.  

A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs.  The company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.  In these areas, Jazz Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Defitelio® (defibrotide sodium) and Vyxeostm (daunorubicin and cytarabine) liposome for injection in the U.S. and markets Erwinase® and Defitelio® (defibrotide) in countries outside the U.S.  For more information, please visit www.jazzpharmaceuticals.com.

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

SOURCE Jazz Pharmaceuticals plc


These press releases may also interest you

at 13:17
Global Genes, a leading rare disease patient advocacy organization, is pleased to announce the 4th Annual virtual Denim Dash 5k for rare diseases Wednesday, July 4 ? Monday, September 3, 2018. The virtual Denim Dash 5k offers participants across the...

at 13:10
athenahealth, Inc. , a leading provider of network-enabled services for hospital and ambulatory customers nationwide, issued the following statement in response to the press release and letter issued today by Elliott Management: The athenahealth...

at 13:01
Medical Products & Related Solutions, Distributors & Suppliers, Evacuation Products, Mobile Shelters & Medical FacilitiesRead the full report: https://www.reportlinker.com/p05171205 Report DetailsThe latest report from business intelligence provider...

at 13:00
The "Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application - Global Forecasts to 2023 " report has been added to ResearchAndMarkets.com's offering. The...

at 13:00
"I wanted to offer relief from nasal congestion and other uncomfortable problems caused by the common cold," said an inventor from New Rochelle, N.Y. "This invention provides a comfortable and efficient way to remove impurities from the ears, nose...

at 13:00
Strategy and Related Feasibility Study Call for the Expansion of the MPP's Mandate to Patented Medicines on the World Health Organization's Model List of Essential Medicines   The Medicines Patent Pool Foundation (MPP) released its five-year...




News published on 7 december 2017 at 16:05 and distributed by: